Search

Abstract: 11C-methionine positron emission tomography (11C-methionine PET) provides accurate detection of brain tumors. Several reports have analyzed the correlation between uptake of 11C-methionine and Ki-67 index or microvessel density non-stereotactically and suggested that 11C-methionine uptake reflects both proliferation potential and angiogenic capability in gliomas. As gliomas possess heterogeneous histological architecture, non-stereotactic comparison of the histology and 11C-methionine PET image may not be accurate. In the present study, the correlation between 11C-methionine uptake and cell or microvessel density was analyzed using histological specimens obtained by stereotactic biopsy, and an exact local comparison of 11C-methionine PET image and histological specimens was conducted. The tumor/normal tissue (T/N) ratio of 11C-methionine positron emission tomography was found to correlate better with cell density (R =0.747, p =0.000042) and Ki-67 index (R =0.675, p =0.00041) than with microvessel density (R =0.467, p =0.025) in a histological comparison using a stereotactic image. Furthermore, multiple linear regression analysis revealed that cell density was the key determinant for predicting 11C-methionine level while microvessel density was not. These results suggest that cell density contributes more to 11C-methionine uptake than microvessel density in glioma tissues and that the previously reported correlation of 11C-methionine uptake and microvessel density in glioma patients requires reevaluation. [Copyright &y& Elsevier]

Abstract: Multimodal imaging is one of the necessary steps in the treatment of malignant brain tumors, and use of magnetic resonance imaging (MRI) and positron emission tomography (PET) are the current gold standard technique for the morphological and biological assessment of malignant brain tumors. In addition, fractional anisotropy (FA) obtained from diffusion tensor imaging (DTI) and 11C-methionine PET are useful to determine the tumor border at the tumor and white matter interface. Although there is no question of their value, a universally accepted cut-off value to discriminate normal and abnormal tissue has not been established. In this study we attempted to calculate and determine the cut-off values in FA and 11C-methionine PET that will allow delineation of the tumor border at the tumor and white matter interface by combining these two modalities. We were able to determine individual cut-off values for 11 patients, and then found an average cut-off value in the T/N ratio of 11C-methionine PET of 1.27 and in FA of 0.26, values similar to those previously confirmed by histological study. Moreover, reconstructing images delineating the tumor border was possible combining these two imaging modalities. We propose that the combined analysis of DTI and 11C-methionine PET has the potential to improve tumor border imaging in glioma patients, providing important information for establishing neurosurgical strategies. [Copyright &y& Elsevier]